original_name,protein_id,Gene,Gene synonym,Ensembl,Gene description,Chromosome,Position,Protein class,Biological process,Molecular function,Disease involvement,Evidence,HPA evidence,UniProt evidence,NeXtProt evidence,RNA tissue specificity,RNA tissue distribution,RNA tissue specificity score,RNA tissue specific nTPM,RNA single cell type specificity,RNA single cell type distribution,RNA single cell type specificity score,RNA single cell type specific nTPM,RNA cancer specificity,RNA cancer distribution,RNA cancer specificity score,RNA cancer specific FPKM,RNA brain regional specificity,RNA brain regional distribution,RNA brain regional specificity score,RNA brain regional specific nTPM,RNA blood cell specificity,RNA blood cell distribution,RNA blood cell specificity score,RNA blood cell specific nTPM,RNA blood lineage specificity,RNA blood lineage distribution,RNA blood lineage specificity score,RNA blood lineage specific nTPM,RNA cell line specificity,RNA cell line distribution,RNA cell line specificity score,RNA cell line specific nTPM,RNA tissue cell type enrichment,RNA mouse brain regional specificity,RNA mouse brain regional distribution,RNA mouse brain regional specificity score,RNA mouse brain regional specific nTPM,RNA pig brain regional specificity,RNA pig brain regional distribution,RNA pig brain regional specificity score,RNA pig brain regional specific nTPM,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Secretome location,Secretome function,CCD Protein,CCD Transcript,Blood concentration - Conc. blood IM [pg/L],Blood concentration - Conc. blood MS [pg/L],Blood expression cluster,Tissue expression cluster,Brain expression cluster,Cell line expression cluster,Single cell expression cluster,Interactions,Subcellular main location,Subcellular additional location,Antibody RRID,Pathology prognostics - Breast cancer,Pathology prognostics - Cervical cancer,Pathology prognostics - Colorectal cancer,Pathology prognostics - Endometrial cancer,Pathology prognostics - Glioma,Pathology prognostics - Head and neck cancer,Pathology prognostics - Liver cancer,Pathology prognostics - Lung cancer,Pathology prognostics - Melanoma,Pathology prognostics - Ovarian cancer,Pathology prognostics - Pancreatic cancer,Pathology prognostics - Prostate cancer,Pathology prognostics - Renal cancer,Pathology prognostics - Stomach cancer,Pathology prognostics - Testis cancer,Pathology prognostics - Thyroid cancer,Pathology prognostics - Urothelial cancer,sequence
P02768 Albumin 白蛋白,P02768,ALB,,ENSG00000163631,Albumin,4,73397114-73421482,"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins",,,"Cancer-related genes, Disease variant, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in many,136.0,liver: 205952.1,Cell type enriched,Detected in many,4.0,Hepatocytes: 59612.0,Cancer enriched,Detected in many,384.0,liver cancer: 14213.7,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cancer enriched,Detected in many,24.0,liver cancer: 1846.4,"Kidney - Proximal tubular cells, Liver - Hepatocytes",Not detected,Not detected,,,Low region specificity,Detected in all,,,"CAB006262, HPA031024, HPA031025",Enhanced,,Enhanced,"Endoplasmic reticulum,Golgi apparatus",Secreted to blood,Transport,,,40000000000000.0,,,Cluster 31: Liver - Plasma proteins,Cluster 33: Neurons - Mixed function,Cluster 18: Liver cancer - Metabolism,Cluster 43: Hepatocytes - Metabolism,1.0,Golgi apparatus,Endoplasmic reticulum,"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704",unprognostic (1.38e-1),unprognostic (8.72e-2),unprognostic (1.73e-1),unprognostic (2.60e-1),unprognostic (4.44e-1),unprognostic (2.46e-1),unprognostic (9.53e-3),unprognostic (2.16e-2),unprognostic (2.40e-1),unprognostic (6.43e-2),unprognostic (3.84e-2),unprognostic (5.37e-2),unprognostic (1.25e-1),prognostic unfavorable (7.87e-4),unprognostic (7.23e-2),unprognostic (1.05e-3),unprognostic (1.02e-2),MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL
P01871 （Immunoglobulin heavy constant mu）IGHM 免疫球蛋白重常数,P01871,IGHM,,ENSG00000211899,Immunoglobulin heavy constant mu,14,105851705-105856218,"Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity",,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,4.0,intestine: 1279.4;lymphoid tissue: 3116.6,Group enriched,Detected in some,8.0,B-cells: 2732.6;Plasma cells: 9466.1,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Group enriched,Detected in all,16.0,memory B-cell: 4293.6;naive B-cell: 6750.1,Lineage enriched,Detected in all,19.0,B-cells: 6750.1,Cancer enriched,Detected in some,4.0,lymphoma: 1665.3,"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells",Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,CAB008643,Uncertain,,,,Immunoglobulin genes,Immunity,,,,110000000000.0,Cluster 18: Non-specific - Translation,,Cluster 8: Immune cells - Immune response,Cluster 46: Lymphoma - Humoral immune response,Cluster 77: Plasma cells - Protein processing,,,,CAB008643: AB_1617732,unprognostic (2.91e-3),prognostic favorable (6.49e-4),unprognostic (9.30e-3),unprognostic (9.90e-3),unprognostic (2.05e-1),prognostic favorable (3.70e-6),unprognostic (9.61e-3),unprognostic (1.01e-1),unprognostic (1.52e-2),unprognostic (3.23e-3),unprognostic (2.46e-2),unprognostic (7.13e-2),prognostic unfavorable (5.20e-5),unprognostic (3.01e-1),unprognostic (1.76e-1),unprognostic (3.24e-2),unprognostic (6.28e-3),GSASAPTLFPLVSCENSPSDTSSVAVGCLAQDFLPDSITFSWKYKNNSDISSTRGFPSVLRGGKYAATSQVLLPSKDVMQGTDEHVVCKVQHPNGNKEKNVPLPVIAELPPKVSVFVPPRDGFFGNPRKSKLICQATGFSPRQIQVSWLREGKQVGSGVTTDQVQAEAKESGPTTYKVTSTLTIKESDWLGQSMFTCRVDHRGLTFQQNASSMCVPDQDTAIRVFAIPPSFASIFLTKSTKLTCLVTDLTTYDSVTISWTRQNGEAVKTHTNISESHPNATFSAVGEASICEDDWNSGERFTCTVTHTDLPSPLKQTISRPKGVALHRPDVYLLPPAREQLNLRESATITCLVTGFSPADVFVQWMQRGQPLSPEKYVTSAPMPEPQAPGRYFAHSILTVSEEEWNTGETYTCVVAHEALPNRVTERTVDKSTEGEVSADEEGFENLWATASTFIVLFLLSLFYSTTVTLFKVK
P01876 Immunoglobulin heavy constant alpha 1免疫球蛋白重常数,P01876,IGHA1,AL928768.3,ENSG00000211895,Immunoglobulin heavy constant alpha 1,14,105703995-105708665,"Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity",,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in many,,intestine: 7198.9;salivary gland: 4545.3;stomach 1: 6480.0,Cell type enriched,Detected in many,16.0,Plasma cells: 107776.7,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Group enriched,Detected in many,203.0,memory B-cell: 2579.2;naive B-cell: 1123.4,Lineage enriched,Detected in many,282.0,B-cells: 2579.2,Cancer enriched,Detected in some,20.0,Myeloma: 1517.6,"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells",,,,,,,,,"HPA001217, HPA006013",Approved,,,,Immunoglobulin genes,Immunity,,,,130000000000.0,Cluster 17: B-cells - Immunoglobulins,,Cluster 8: Immune cells - Immune response,Cluster 51: Myeloma - Immunoglobulins,Cluster 77: Plasma cells - Protein processing,,,,"HPA001217: AB_1079120, HPA006013: AB_1079119",prognostic favorable (8.87e-5),unprognostic (5.36e-3),unprognostic (2.10e-2),unprognostic (1.59e-2),unprognostic (3.75e-2),prognostic favorable (3.81e-5),unprognostic (1.17e-1),unprognostic (3.86e-1),unprognostic (2.62e-1),unprognostic (3.26e-2),unprognostic (1.66e-1),unprognostic (1.34e-1),prognostic unfavorable (1.83e-7),unprognostic (8.10e-2),unprognostic (5.08e-2),unprognostic (1.16e-1),unprognostic (2.99e-2),ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSPSCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRVAAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLADWQMPPPYVVLDLPQETLEEETPGANLWPTTITFLTLFLLSLFYSTALTVTSVRGPSGNREGPQY
P01877 Immunoglobulin heavy constant alpha 2免疫球蛋白重常数,P01877,IGHA2,,ENSG00000211890,Immunoglobulin heavy constant alpha 2 (A2m marker),14,105583731-105588395,"Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity",,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in some,23.0,intestine: 562.7,Cell type enriched,Detected in many,30.0,Plasma cells: 9424.7,Low cancer specificity,Detected in all,,,Not detected,Not detected,,,Group enriched,Detected in some,878.0,memory B-cell: 280.4;naive B-cell: 124.8,Lineage enriched,Detected in single,1215.0,B-cells: 280.4,Cancer enriched,Detected in some,5.0,Myeloma: 47.8,"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells",,,,,,,,,"HPA001217, HPA006013",Approved,,,,Immunoglobulin genes,Immunity,,,,67000000000.0,Cluster 17: B-cells - Immunoglobulins,,,Cluster 51: Myeloma - Immunoglobulins,Cluster 77: Plasma cells - Protein processing,,,,"HPA001217: AB_1079120, HPA006013: AB_1079119",prognostic favorable (1.98e-9),unprognostic (3.20e-2),unprognostic (2.23e-2),unprognostic (1.53e-2),unprognostic (1.93e-2),prognostic favorable (8.40e-5),unprognostic (4.56e-2),unprognostic (2.59e-1),unprognostic (3.17e-1),unprognostic (3.69e-2),unprognostic (1.20e-1),unprognostic (1.18e-1),prognostic unfavorable (7.50e-6),unprognostic (2.12e-1),unprognostic (3.28e-2),unprognostic (9.70e-2),unprognostic (4.47e-1),ASPTSPKVFPLSLDSTPQDGNVVVACLVQGFFPQEPLSVTWSESGQNVTARNFPPSQDASGDLYTTSSQLTLPATQCPDGKSVTCHVKHYTNSSQDVTVPCRVPPPPPCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGATFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAQPWNHGETFTCTAAHPELKTPLTANITKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTYAVTSILRVAAEDWKKGETFSCMVGHEALPLAFTQKTIDRMAGSCCVADWQMPPPYVVLDLPQETLEEETPGANLWPTTITFLTLFLLSLFYSTALTVTSVRGPSGKREGPQY
P01857 Immunoglobulin heavy constant gamma 1免疫球蛋白重常数1,P01857,IGHG1,,ENSG00000211896,Immunoglobulin heavy constant gamma 1 (G1m marker),14,105736343-105743071,"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins","Adaptive immunity, Immunity",,FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Group enriched,Detected in many,7.0,lymphoid tissue: 5665.1;urinary bladder: 3867.4,Cell type enriched,Detected in many,5.0,Plasma cells: 12047.8,Low cancer specificity,Detected in all,,,Low region specificity,Detected in many,,,Immune cell enriched,Detected in some,6.0,memory B-cell: 768.6,Lineage enriched,Detected in many,122.0,B-cells: 768.6,Cancer enriched,Detected in some,8.0,Myeloma: 1184.5,"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells",,,,,,,,,"HPA001245, CAB008642",Supported,,,,Immunoglobulin genes,Immunity,,,,230000000000.0,Cluster 17: B-cells - Immunoglobulins,,Cluster 8: Immune cells - Immune response,Cluster 51: Myeloma - Immunoglobulins,Cluster 77: Plasma cells - Protein processing,1.0,,,"CAB008642: AB_1617595, HPA001245: AB_1079121",unprognostic (6.47e-3),unprognostic (4.39e-3),unprognostic (2.91e-2),unprognostic (2.32e-3),unprognostic (1.55e-2),prognostic favorable (2.67e-4),unprognostic (3.90e-2),unprognostic (3.25e-1),unprognostic (7.52e-2),unprognostic (5.36e-3),unprognostic (8.06e-2),unprognostic (1.09e-1),prognostic unfavorable (2.49e-9),unprognostic (3.12e-1),unprognostic (3.52e-1),unprognostic (8.96e-2),unprognostic (7.61e-2),ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPELQLEESCAEAQDGELDGLWTTITIFITLFLLSVCYSATVTFFKVKWIFSSVVDLKQTIIPDYRNMIGQGA
